Related Experiment Videos
Anthracycline adjuvant chemotherapy: how much is enough?
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Breast cancer diagnosis and treatment wait times in specialized diagnostic units compared with usual care: a population-based study.
Current oncology (Toronto, Ont.)·2020
Baseline staging imaging for distant metastasis in women with stages I, II, and III breast cancer.
Current oncology (Toronto, Ont.)·2020
Cost-utility analysis of 21-gene assay for node-positive early breast cancer.
Current oncology (Toronto, Ont.)·2019
Impact of a novel prioritization framework on clinician-led oncology drug submissions.
Current oncology (Toronto, Ont.)·2019
Ataxia-telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review.
Current oncology (Toronto, Ont.)·2018
Darolutamide Alone and in Combination With Goserelin in Androgen Receptor-Positive Salivary Gland Carcinoma: Results From the Phase II DISCOVARY Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
High-Risk Smoldering Multiple Myeloma: A Review of Controversies in Early Treatment Versus Observation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Long-Term Clinical Outcomes of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory ALL.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026